224 related articles for article (PubMed ID: 9262882)
1. Do pseudoephedrine or phenylpropanolamine improve maximum oxygen uptake and time to exhaustion?
Swain RA; Harsha DM; Baenziger J; Saywell RM
Clin J Sport Med; 1997 Jul; 7(3):168-73. PubMed ID: 9262882
[TBL] [Abstract][Full Text] [Related]
2. The acute effect of phenylpropanolamine and brompheniramine on blood pressure in controlled hypertension: a randomized double-blind crossover trial.
Petrulis AS; Imperiale TF; Speroff T
J Gen Intern Med; 1991; 6(6):503-6. PubMed ID: 1684991
[TBL] [Abstract][Full Text] [Related]
3. Double-blind, randomized, placebo-controlled clinical trials with non-prescription medications for the treatment of obesity.
Greenway F; Herber D; Raum W; Herber D; Morales S
Obes Res; 1999 Jul; 7(4):370-8. PubMed ID: 10440593
[TBL] [Abstract][Full Text] [Related]
4. Elimination of ephedrines in urine following multiple dosing: the consequences for athletes, in relation to doping control.
Chester N; Mottram DR; Reilly T; Powell M
Br J Clin Pharmacol; 2004 Jan; 57(1):62-7. PubMed ID: 14678341
[TBL] [Abstract][Full Text] [Related]
5. Physiological, subjective and performance effects of pseudoephedrine and phenylpropanolamine during endurance running exercise.
Chester N; Reilly T; Mottram DR
Int J Sports Med; 2003 Jan; 24(1):3-8. PubMed ID: 12582945
[TBL] [Abstract][Full Text] [Related]
6. Transient hypertension after two phenylpropanolamine diet aids and the effects of caffeine: a placebo-controlled follow-up study.
Lake CR; Zaloga G; Bray J; Rosenberg D; Chernow B
Am J Med; 1989 Apr; 86(4):427-32. PubMed ID: 2929629
[TBL] [Abstract][Full Text] [Related]
7. Pseudoephedrine ingestion and cycling time-trial performance.
Pritchard-Peschek KR; Jenkins DG; Osborne MA; Slater GJ
Int J Sport Nutr Exerc Metab; 2010 Apr; 20(2):132-8. PubMed ID: 20479486
[TBL] [Abstract][Full Text] [Related]
8. Caffeine effects on VO
Brietzke C; Asano RY; De Russi de Lima F; Pinheiro FA; Franco-Alvarenga ; Ugrinowitsch C; Pires FO
Nutr Health; 2017 Dec; 23(4):231-238. PubMed ID: 29214920
[TBL] [Abstract][Full Text] [Related]
9. Serum concentrations of phenylpropanolamine and associated effects on blood pressure in normotensive subjects: a pilot-study.
Dowse R; Scherzinger SS; Kanfer I
Int J Clin Pharmacol Ther Toxicol; 1990 May; 28(5):205-10. PubMed ID: 2194987
[TBL] [Abstract][Full Text] [Related]
10. Muscular and cardiorespiratory effects of pseudoephedrine in human athletes.
Gill ND; Shield A; Blazevich AJ; Zhou S; Weatherby RP
Br J Clin Pharmacol; 2000 Sep; 50(3):205-13. PubMed ID: 10971304
[TBL] [Abstract][Full Text] [Related]
11. Effects of phenylpropanolamine and isometric exercise on blood pressure.
Pentel PR; Eisen T
Int J Obes; 1988; 12(3):199-204. PubMed ID: 3391736
[TBL] [Abstract][Full Text] [Related]
12. The effect of multiple doses of phenylpropanolamine on the blood pressure of patients whose hypertension was controlled with beta blockers.
O'Connell MB; Gross CR
Pharmacotherapy; 1991; 11(5):376-81. PubMed ID: 1684039
[TBL] [Abstract][Full Text] [Related]
13. Changes in blood pressure following escalating doses of phenylpropanolamine and a suggested protocol for monitoring.
Segev G; Westropp JL; Kulik C; Lavy E
Can Vet J; 2015 Jan; 56(1):39-43. PubMed ID: 25565712
[TBL] [Abstract][Full Text] [Related]
14. Therapeutic doses of phenylpropanolamine increase supine systolic blood pressure.
Pentel PR; Aaron C; Paya C
Int J Obes; 1985; 9(2):115-9. PubMed ID: 4030197
[TBL] [Abstract][Full Text] [Related]
15. The effect of salbutamol on performance in elite nonasthmatic athletes.
Meeuwisse WH; McKenzie DC; Hopkins SR; Road JD
Med Sci Sports Exerc; 1992 Oct; 24(10):1161-6. PubMed ID: 1435165
[TBL] [Abstract][Full Text] [Related]
16. Effects of caffeine, ephedrine and their combination on time to exhaustion during high-intensity exercise.
Bell DG; Jacobs I; Zamecnik J
Eur J Appl Physiol Occup Physiol; 1998 Apr; 77(5):427-33. PubMed ID: 9562293
[TBL] [Abstract][Full Text] [Related]
17. The effect of phenylpropanolamine on blood pressure during upright bicycle exercise in normal subjects.
Davies SF; McArthur CD; Husebye DG; Maddy MM; O'Connell MB; Pentel PR
Int J Obes; 1989; 13(4):505-10. PubMed ID: 2676877
[TBL] [Abstract][Full Text] [Related]
18. Pseudoephedrine and circadian rhythm interaction on neuromuscular performance.
Pallarés JG; López-Samanes Á; Fernández-Elías VE; Aguado-Jiménez R; Ortega JF; Gómez C; Ventura R; Segura J; Mora-Rodríguez R
Scand J Med Sci Sports; 2015 Dec; 25(6):e603-12. PubMed ID: 25515692
[TBL] [Abstract][Full Text] [Related]
19. Hypertension, exercise, and beta-adrenergic blockade.
Ades PA; Gunther PG; Meacham CP; Handy MA; LeWinter MM
Ann Intern Med; 1988 Oct; 109(8):629-34. PubMed ID: 2901818
[TBL] [Abstract][Full Text] [Related]
20. Phase I, double-blind, randomized, placebo-controlled, dose-escalation study of the effects on blood pressure of abrupt cessation versus taper down of guanfacine extended-release tablets in adults aged 19 to 24 years.
Kisicki JC; Fiske K; Lyne A
Clin Ther; 2007 Sep; 29(9):1967-79. PubMed ID: 18035196
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
